CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2011	Dec. 31, 2010
Current assets:
Cash	$ 252,249	$ 310
Grant receivable		223,540
Due from related party	15,491
Due from officers	7,714
Inventory	678,123	308,662
Prepaid expenses	17,675	211,717
Total current assets	971,252	744,229
Other assets:
Patent and trademark costs, net	1,387,104	1,467,623
Office furniture and fixtures, net	7,862
Deferred private placement costs		587,133
Deferred debt isuance costs, net	22,405
Deposits		1,535
Total other assets	1,417,371	2,056,291
Total assets	2,388,623	2,800,520
Current liabilities:
Demand bank loans	174,925	174,925
Accounts payable	1,064,892	2,900,684
Accrued interest payable to shareholders	21,502	190,977
Accrued expenses	545,578	227,724
Deferred grant revenue		223,540
Notes payable to shareholders, net of unamortized discount	25,000	1,095,643
Notes payable	400,000
Convertible notes, net of unamortized discount	641,886
Due to related party		6,942
Due to officers		3,200
Total current liabilities	2,873,783	4,823,635
Long term notes payable to shareholders, net of unamortized discount	140,000	65,557
Long term portion of notes payables	37,000
Warrant liability	550,000
Total liabilities	3,600,783	4,889,192
Commitments and contingencies (Note 11)
Capital stock issued and outstanding:
0 preferred shares
27,209,646 common shares (16,000,000 at December 31, 2010)	273
Capital in excess of par value	5,822,882	3,598,856
Accumulated deficit	(7,041,297)	(5,687,394)
Non-controlling interest - consolidated subsidiary	5,982	(134)
Total shareholders' deficit	(1,212,160)	(2,088,672)
Total liabilities and shareholders' deficit	$ 2,388,623	$ 2,800,520